The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

This open line of communication led his doctor to prescribe TRELEGY ELLIPTA (fluticasone furoate 100 mcg, umeclidinium 62.5 mcg, and vilanterol 25 mcg inhalation powder), a once-daily treatment for ...

Inhalers and nebulizers are devices that deliver medicine directly into the lungs. The difference between the two devices is in the way they deliver the medication. An inhaler relies on pressure, ...

A salt pipe is an inhaler containing salt particles. Advocates of salt pipes suggest they help with many health conditions, including asthma, but scientific support is limited. Salt therapy ...

CMS is expected to announce in early 2025 the list of up to 15 Medicare Part D drugs that will be subject to price negotiations in 2025, with negotiated prices expected to be implemented in 2027.

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change. While these inhalers are critically important to saving lives and making it ...

The TechSilen Tinnitus Inhaler has emerged as a promising contender, thanks to its unique formulation and fast-acting relief properties. In this comprehensive review, we will delve into the ...

Sub-optimally controlled asthma is common, in part because of normalisation of symptoms, underuse of preventer therapy, overuse of reliever therapy, and poor inhaler technique. Ensuring patients are ...

The tobacco giant that makes Marlboro cigarettes has sold a UK inhaler company for a knock-down price due to what it calls an "unwarranted" backlash. Philip Morris International (PMI) has ...

Many of us with chronic obstructive pulmonary disease (COPD) have received medical devices to help with our breathing. At first, it seemed to me that some of these devices worked better than others.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Philip Morris International has agreed to sell its Vectura asthma inhaler maker for only a third of what it ...